•Bausch + Lomb's oral dry AMD therapy advances to clinical evaluation •Glaukos reports positive 3-year, phase 3 Epioxa clinical outcomes•GLP-1 drugs increase risk for periorbital changes•SpyGlass Pharma unveils positive 12-month data on BIM-IOL System•Academy in NOLA: retina durability, gene therapies, and TED data lead clinical highlights •Bausch + Lomb's oral dry AMD therapy advances to clinical evaluation •Glaukos reports positive 3-year, phase 3 Epioxa clinical outcomes•GLP-1 drugs increase risk for periorbital changes•SpyGlass Pharma unveils positive 12-month data on BIM-IOL System•Academy in NOLA: retina durability, gene therapies, and TED data lead clinical highlights
HEADLINES
FEATURED
American Academy of Ophthalmology’s annual meeting heads to the Big Easy with new product launches and industry news.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
